surpass tirzepatide New research from the SURPASS-EARLY trial found that improved glycemic control, body weight, and waist circumference over 104 weeks compared with intensified conventional care in adults with early type 2 diabetes 💡 New insight in diabetes

After consulting her healthcare provider, she started GLP-1 medication and noticed significant progress in just a few months

Thats what led me to GLP-1s

Issues 15, 169174

Digbi Healths Precision GLP-1 Program includes: Clinically supervised access to FDA-approved GLP-1 medications, including Wegovy, Ozempic, and Zepbound, with access to an introductory cash price of $199 per month for Ozempic and Wegovy injection pens for Digbi self-pay users, along with clear, transparent pricing and no hidden fees

[DOI] [PubMed] [Google Scholar] 492.MacDonald P.E., Wang X., Xia F., El-kholy W., Targonsky E.D., Tsushima R.G

This measured approach gives your gastrointestinal system time to adjust, reducing the likelihood of severe nausea or vomiting that can interfere with treatment adherence